已收盤 12-24 16:00:00 美东时间
-0.020
-0.16%
OSCR大涨超22%,白宫计划延长奥巴马医改补贴;加密财库公司BitMine大涨19.6%,持有3%的ETH代币供应量>>
11-25 15:10
Transaction Expands Fulton's Presence in Highly Attractive New Jersey MarketsLANCASTER, Pa. and RUTHERFORD, N.J., Nov. 24, 2025 /PRNewswire/ -- Fulton Financial Corporation (NASDAQ:FULT) ("Fulton") and Blue Foundry
11-24 21:48
Transaction Expands Fulton's Presence in Highly Attractive New Jersey Markets LANCASTER, Pa. and RUTHERFORD, N.J., Nov. 24, 2025 /PRNewswire/ -- Fulton Financial Corporation (Nasdaq: FULT) (...
11-24 21:45
Blue Foundry (NASDAQ:BLFY) reported quarterly losses of $(0.10) per share which met the analyst consensus estimate. This is a 47.37 percent increase over losses of $(0.19) per share from the same period last year. The
10-29 20:16
Companies Reporting Before The Bell • OppFi (NYSE:OPFI) is expected to report q...
10-29 19:11
Blue Foundry (NASDAQ:BLFY) reported quarterly losses of $(0.10) per share which beat the analyst consensus estimate of $(0.12) by 16.67 percent. This is a 9.09 percent increase over losses of $(0.11) per share from the
07-30 20:16
Blue Foundry Bancorp will release Q2 2025 financial results on July 30, 2025, followed by a conference call at 11:00 AM ET. Investors and analysts can join via webcast or dial-in. The earnings release will be available on the Company’s website and the SEC’s site. Blue Foundry Bancorp, the holding company for Blue Foundry Bank, serves communities in New Jersey and offers tailored banking products and services. For more information, contact James D...
07-09 12:15
Blue Foundry Bancorp (NASDAQ:BLFY) has adopted its sixth stock repurchase program to repurchase up to 1.08M shares of the company’s common stock, which is approximately 5% of its outstanding common st...
06-24 05:35
Blue Foundry Bancorp has announced its sixth stock repurchase program, authorizing the repurchase of up to 1,082,533 shares, or approximately 5% of its outstanding common stock. The program began on June 20, 2025. Since the first program in July 2022, the company has repurchased 7,798,723 shares, or 27.3% of its common shares, at a weighted average price of $10.09. Repurchases will be conducted in open market or private transactions, with timing ...
06-23 21:28
Oppenheimer:上调Ovid Therapeutics(OVID)评级至"跑赢大市",目标价4美元
01-31 15:37